Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Details )

v3.26.3
Stockholders' Equity (Details ) - Twin Vee [Member] - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]        
Number of options outstanding at beginning of period 6,239 5,757 5,757  
Weighted average exercise price at beginning of period $ 966.77 $ 1,084.53 $ 1,084.53  
Weighted average remaining life (years) 5 years 2 months 8 days 5 years 2 months 8 days 7 years 5 months 8 days 5 years 14 days
Grant date fair value of options at beginning of period $ 1,597,681 $ 1,699,877 $ 1,699,877  
Number of options, Granted 1,944    
Weighted average exercise price, Granted $ 0 $ 100.27    
Grant date fair value of options, Granted $ 0 $ 98,271    
Number of options, Exercised    
Weighted average exercise price, Exercised $ 0 $ 0    
Grant date fair value of options, exercised $ 0 $ 0    
Number of options, Expired (157) (112)    
Weighted average exercise price, Expired $ (733.06) $ (1,029.66)    
Grant date fair value of options, Expired $ (23,096) $ (50,224)    
Number of options, Forfeited/canceled (1) (1,008)    
Weighted average exercise price, Forfeited/canceled $ (421.80) $ (186.86)    
Grant date fair value of options, Forfeited/canceled $ (30) $ (98,080)    
Number of options outstanding at ending of period 6,081 6,581 6,239 5,757
Weighted average exercise price at ending of period $ 972.90 $ 932.22 $ 966.77 $ 1,084.53
Grant date fair value of options at ending of period $ 1,574,555 $ 1,649,845 $ 1,597,681 $ 1,699,877
Number of options, Exercisable options 5,128 4,415    
Weighted average exercise price, Exercisable options $ 1,132.88 $ 1,309.62    
Weighted average remaining life (years) 6 years 6 months 21 days 6 years 6 months 18 days    
Grant date fair value of exercisable options at of period $ 1,522,899 $ 1,502,532